The Top 25 Women Leaders in Biotechnology of 2020

Share Article

The Healthcare Technology Report is pleased to announce The Top 25 Women Leaders in Biotechnology of 2020

The Healthcare Technology Report is pleased to announce The Top 25 Women Leaders in Biotechnology of 2020. These accomplished women have led a wide range of initiatives supporting the development of treatments for complex diseases and other illnesses. In light of the current pandemic, some have also provided guidance, through their high-level roles, toward the research and development of treatments that will ultimately curb the spread of COVID-19. Overall as a group, their business expertise, clinical acumen, strategic decision making, and overall passion for creating medicines to heal others has led them to consistently achieve and thrive in an ever evolving industry.

The women recognized on this year’s list have contributed to major growth and development within their companies. For example, Angela Hwang is the Group President of Pfizer’s Biopharmaceutical Group – the division which comprises 80% of Pfizer’s revenue. She leads 26,000 colleagues in bringing over 600 products and medicines to patients and aided the group in achieving approximately $40 billion in revenue last year. Furthermore, two companies saw multiple awardees; GRAIL, Inc. and STEMCELL Technologies each had two awardees on this year’s list, demonstrating the impact that a strong corporate culture can have in producing leaders.

Through the depth and breadth of their knowledge, as well as their ability to lead highly efficient teams, these women stand out as role models for the next generation of women in healthcare and biotechnology. Please join The Healthcare Technology Report Team in celebrating the achievements of The Top 25 Women Leaders in Biotechnology of 2020.

Angela Hwang (Pfizer), Andrea Wainer (Abbott), Ginger Gregory (Biogen), Kimberly Smith (ViiV Healthcare), Joan Sheehan (STEMCELL Technologies), Helen Sheridan (STEMCELL Technologies), Lee Ann Kimak (Bavarian Nordic), Sheila Gujrathi (Gossamer Bio), Angela Huskey (Millennium Health), Alice Chen (GRAIL, Inc.), Marissa Lee Song (GRAIL, Inc.), Cynthia Pointer (ArcherDX), Heather Steinman (The Wistar Institute), Pia Olson (Ora, Inc.), Anne Jones (Genuity Science), Christiane Buisson (Cerba Research), Natalie Bartlett (ZAGENO), Dalia Argaman (EarlySense), Jennifer Burdman (PolarityTE), Irina Sher (Bioforum), Priya Mande (PsiOxus Therapeutics), Li Xu (Transcenta), Laura Ayala (Karius), Terry Crandall (Ironshore Pharmaceuticals), and Veronica Hughes (US HealthVest).

About The Healthcare Technology Report

The Healthcare Technology Report provides market research and insights, business news, investment activity updates and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers and media professionals highly knowledgeable on healthcare technology and the various companies, executives and investors that make up the sector.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jerald Hapitan
Visit website